Total Funding
15
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 15 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
565669
ev3 is a global technology solutions provider for specialists treating a wide range of vascular diseases and disorders.
- Kumar Surinder: Founder
Bob Palmisano: CEOPast Role: Summit Group, Chief Executive Officer
About the Company
ev3 is a global leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty
balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons..
With a legacy in technology development and innovation, ev3 is helping endovascular specialists around the world perform more efficiently, effectively and predictably.
ev3. Your endovascular company.


